Newco will be renamed “Viatris,” effective as of closing of the Combination. When the transactions are completed, Mylan shareholders as of immediately prior to the Combination will hold 43% of the fully diluted outstanding shares of common stock of Newco.
That’s because Viatris was formed through the merger of Mylan and Upjohn, the generics unit of Pfizer ( PFE 4.26% ). Pfizer shareholders were given a little more than 12 shares in Viatris for every 100 they held in Pfizer. Mylan shareholders got a Viatris share for every previous Mylan share they held.
Will Viatris pay a dividend?
Adding in the third dividend payment of the year and assuming a flat share count, Viatris will have paid about $400 million in dividends in 2021. Against the $2.5 billion in midpoint free cash flow that Viatris is forecasting for 2021, this equates to a 16% payout ratio.
Is Viatris stock a good value?
Valuation metrics show that Viatris Inc. may be undervalued. Its Value Score of A indicates it would be a good pick for value investors. The financial health and growth prospects of VTRS, demonstrate its potential to outperform the market.
Where did my Viatris stock come from?
As already noted, Viatris was formed through the merger of Mylan and Pfizer’s Upjohn division. Mylan was well-known for its highly leveraged balance sheet and also Pfizer contributed its share, by off-loading roughly $11.2 billion and $1.9 billion in long- and short-term debt, respectively.
What is the cost basis for Viatris?
This results in a tax basis of approximately $4.19 per share, with approximately $519.67 allocated to the 124 shares received of Viatris common stock and approximately $0.33 allocated to the Viatris fractional share in respect of which cash is received.
When did Viatris buy Mylan?
After nearly 60 years, Mylan makes way for Viatris. The merger, announced in late July 2019, took effect Monday.
What does Viatris Inc do?
Products. The company produces and sells a variety of medicines, with 1,400 approved therapeutic molecules in its portfolio. It owns brands (like Viagra, Xanax, Lipitor), generics, including branded and complex generics, biosimilars, and over-the-counter (OTC) drugs and active pharmaceutical ingredients.
When did Viatris start paying dividends?
On May 7, 2021, Viatris’ Board of Directors declared the Company’s first quarterly cash dividend of $0.11 per share on the Company’s issued and outstanding common stock.
Is Viatris a good buy now?
Conclusions. Viatris is a very solid company. With stable revenues, earnings, and free cash flow, the company can serve its debt easily and reward investors with a growing dividend.
Who spun off Viatris?
Pfizer recently completed a spin-off of it’s Upjohn business, combining it with Mylan N.V. to form a new entity, Viatris, which began trading on 11/16/2020 under the ticker symbol VTRS.
Is Mylan owned by Pfizer?
Now that the FTC has formally cleared the merger, the new firm, Viatris, will become a generics giant, with Pfizer owning 57% and Mylan owning 43%.
Is Viatris a Pfizer company?
Viatris was formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including our global workforce of ~38,000, we aim to deliver increased access to affordable, quality medicines for patients worldwide.